Suzhou Highfine Biotech Co., Ltd. (SHE:301393)

China · Delayed Price · Currency is CNY

62.40

-0.87 (-1.38%)

At close: Oct 9, 2026

Market Cap	6.69B +20.5%
Revenue (ttm)	711.19M +43.1%
Net Income	109.51M -24.0%
EPS	1.02 -23.2%
Shares Out	107.18M
PE Ratio	61.17
Forward PE	n/a
Dividend	0.41 (0.65%)
Ex-Dividend Date	May 21, 2026

Volume	3,366,947
Open	63.09
Previous Close	63.27
Day's Range	58.51 - 63.34
52-Week Range	46.69 - 74.68
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2026

About Suzhou Highfine Biotech

Suzhou Highfine Biotech Co., Ltd. manufactures and sells chemicals for pharmaceutical research and development, and API production companies in China. The company’s products include building blocks, protein reagents, protein crosslinkers, liposomes, ionic liquids, protective amino acids, unnatural amino acids, nucleotide reagents, etc. Its products are used in fields of peptide, nucleotide, and pharmaceutical synthesis. Suzhou Highfine Biotech Co., Ltd. was founded in 2003 and is based in Suzhou, China. [Read more]

Industry Pharmaceutical Preparations

Founded 2003

Employees 678

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301393

Full Company Profile

Financial Performance

In 2025, Suzhou Highfine Biotech's revenue was 602.26 million, an increase of 33.28% compared to the previous year's 451.87 million. Earnings were 114.65 million, a decrease of -14.47%.

Financial Statements